SCHEMBL29618325

SCHEMBL29618325

NS(=O)(=O)c1cccc(NC(=O)c2ccc3c(c2)CCC3)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.71
MEN1 O00255 2/20 0.71
RXFP1 Q9HBX9 1/20 0.71
NPC1 O15118 7/20 0.62
RAB9A P51151 7/20 0.62
CA1 P00915 5/20 0.60
CA2 P00918 5/20 0.60
CA12 O43570 3/20 0.56
CA9 Q16790 2/20 0.56
POLB P06746 1/20 0.56
CASP6 P55212 1/20 0.56
CTDSP1 Q9GZU7 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.55
HTT P42858 3/20 0.55
NFKB1 P19838 2/20 0.55
NFKB2 Q00653 2/20 0.55
RELA Q04206 2/20 0.55
ALDH1A1 P00352 3/20 0.54
LMNA P02545 3/20 0.54
MAPT P10636 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29664409 0.82 CCNT1 (0.53) KMT2AMEN1RXFP1CA1CA2
SCHEMBL29618343 0.82 CA1 (0.57) KMT2AMEN1RXFP1CA1CA2
SCHEMBL29618348 0.81 NPC1 (0.57) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL29618356 0.79 CA1 (0.57) KMT2AMEN1RXFP1CA1CA2
SCHEMBL11961607 0.79 NPC1 (0.71) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL13764406 0.78 MEN1 (0.76) KMT2AMEN1NPC1RAB9ACA1
SCHEMBL14372397 0.78 MEN1 (0.67) KMT2AMEN1NPC1RAB9ACA1
SCHEMBL14372330 0.78 MEN1 (0.76) KMT2AMEN1NPC1RAB9ACA1
SCHEMBL14372369 0.78 CA1 (0.76) KMT2AMEN1CA1CA2CA12
SCHEMBL14372342 0.78 CA1 (0.71) KMT2AMEN1NPC1RAB9ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022121805-A1 FUSED RING COMPOUND AS NAV1.8 INHIBITOR AND USE THEREOF 成都康弘药业集团股份有限公司 2022-06-16 WO disclosed
CN-114591293-A Fused ring compound as Nav1.8 inhibitor and application thereof 成都康弘药业集团股份有限公司 2022-06-07 CN disclosed